Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy
NCT06696456 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-04-06
Summary
This multi-center, observational, post-intervention long term follow-up (LTFU) study will monitor for safety and efficacy of AAVAnc80-hOTOF in individuals with sensorineural hearing loss due to otoferlin gene mutations who have previously received intracochlear administration of AAVAnc80-hOTOF in the AK-OTOF-101 Clinical Trial.
Conditions
- Otoferlin Gene-mediated Hearing Loss
Sponsors & Collaborators
- collaborator INDUSTRY
-
Akouos, Inc.
lead INDUSTRY
Principal Investigators
-
Peter Marks, M.D. · Eli Lilly and Company
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-11
- Primary Completion
- 2033-04-30
- Completion
- 2033-04-30
Countries
- United States
- Spain
- Taiwan
Study Locations
More Related Trials
-
A Trial of LY3056480 in Patients With SNLH
NCT05061758 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations
NCT07288580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
NCT06722170 ·Status: RECRUITING ·Phase: NA
-
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
NCT05318417 ·Status: RECRUITING ·Phase: NA
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02768662 ·Status: TERMINATED ·Phase: PHASE3
-
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
NCT00589511 ·Status: COMPLETED
-
Implantation of the Cochlear® Nucleus® System in Adults With Single-Sided Deafness
NCT01670006 ·Status: COMPLETED ·Phase: NA
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
NCT06699797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial
NCT03052920 ·Status: COMPLETED ·Phase: NA
-
Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT02105441 ·Status: COMPLETED
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy
NCT03996824 ·Status: RECRUITING
-
The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents
NCT06844071 ·Status: RECRUITING
-
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss
NCT05664100 ·Status: TERMINATED ·Phase: PHASE1
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations
NCT06019481 ·Status: WITHDRAWN
-
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
NCT07032038 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
NCT05776459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
NCT02345031 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss
NCT02132130 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02706730 ·Status: TERMINATED ·Phase: PHASE3
-
Implantation of the Cochlear™ Nucleus® Hybrid S Round Window (S-RW) in Adults
NCT02638883 ·Status: COMPLETED
-
Otoferlin Patient Registry and Natural History Study
NCT05946057 ·Status: RECRUITING
-
Evaluation of the Tympanostomy Tube Delivery System
NCT01202578 ·Status: COMPLETED ·Phase: PHASE2/PHASE3